Quote from cunparis:
Very interesting thread, I see I'm not the only one. Thanks for the link.
The bottom line is that if one depends on the open price for a strategy (to verify against previous tests or backtesting) then it's best to skip the NYSE. MOO is unpredictable.
I'll experiment with how a limit order will work for me, but it complicates things because I'll have to tag my journal entries NYSE and do the status on them separately.
